NZ330041A - 1-(benzo fused oxygen and/or sulphur containing heterocyclic ring)-piperidine derivatives and medicaments - Google Patents
1-(benzo fused oxygen and/or sulphur containing heterocyclic ring)-piperidine derivatives and medicamentsInfo
- Publication number
- NZ330041A NZ330041A NZ330041A NZ33004198A NZ330041A NZ 330041 A NZ330041 A NZ 330041A NZ 330041 A NZ330041 A NZ 330041A NZ 33004198 A NZ33004198 A NZ 33004198A NZ 330041 A NZ330041 A NZ 330041A
- Authority
- NZ
- New Zealand
- Prior art keywords
- medicaments
- piperidine derivatives
- heterocyclic ring
- containing heterocyclic
- sulphur containing
- Prior art date
Links
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title 1
- 239000005864 Sulphur Substances 0.000 title 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 title 1
- 239000001301 oxygen Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9703760A FR2761358B1 (fr) | 1997-03-27 | 1997-03-27 | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ330041A true NZ330041A (en) | 1999-01-28 |
Family
ID=9505236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ330041A NZ330041A (en) | 1997-03-27 | 1998-03-26 | 1-(benzo fused oxygen and/or sulphur containing heterocyclic ring)-piperidine derivatives and medicaments |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5965575A (enExample) |
| EP (1) | EP0867436B1 (enExample) |
| JP (1) | JPH10279578A (enExample) |
| CN (1) | CN1090628C (enExample) |
| AT (1) | ATE268767T1 (enExample) |
| AU (1) | AU731018B2 (enExample) |
| BR (1) | BR9803295A (enExample) |
| CA (1) | CA2232116C (enExample) |
| DE (1) | DE69824332T2 (enExample) |
| DK (1) | DK0867436T3 (enExample) |
| ES (1) | ES2223110T3 (enExample) |
| FR (1) | FR2761358B1 (enExample) |
| NO (1) | NO314628B1 (enExample) |
| NZ (1) | NZ330041A (enExample) |
| PL (1) | PL194118B1 (enExample) |
| PT (1) | PT867436E (enExample) |
| ZA (1) | ZA982607B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2782515B1 (fr) * | 1998-08-21 | 2000-09-22 | Adir | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
| EP1146871A4 (en) * | 1999-01-28 | 2002-04-17 | Bristol Myers Squibb Co | HETEROCYCLIC ANTIDEPRESSANT COMPOUNDS |
| PT1189900E (pt) * | 1999-06-30 | 2004-05-31 | Bristol Myers Squibb Co | Derivados de aminopirrolidina heterociclicos utilizados como agentes melatonergicos |
| GB0013737D0 (en) | 2000-06-07 | 2000-07-26 | Astrazeneca Ab | Novel compounds |
| SE0103646D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic chroman compounds |
| CA2434015A1 (en) * | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic chroman compounds |
| NZ535574A (en) | 2001-01-16 | 2006-07-28 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| SE0103650D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| WO2002069973A1 (en) * | 2001-03-02 | 2002-09-12 | Sepracor, Inc. | Piperidine-piperazine ligand for neurotransmitter receptors |
| SE0103836D0 (sv) * | 2001-11-16 | 2001-11-16 | Astrazeneca Ab | Novel compounds |
| JP2005343790A (ja) * | 2002-05-31 | 2005-12-15 | Ajinomoto Co Inc | カルシウムチャネル拮抗薬を含有する医薬組成物 |
| SE0300480D0 (sv) | 2003-02-21 | 2003-02-21 | Astrazeneca Ab | Novel compounds |
| GB0312609D0 (en) | 2003-06-02 | 2003-07-09 | Astrazeneca Ab | Novel compounds |
| MXPA05013553A (es) * | 2003-06-30 | 2006-03-09 | Altana Pharma Ag | Pirrolodihidroisoquinolinas como inhibidores de pde10. |
| EP1641457B1 (en) * | 2003-06-30 | 2009-08-05 | Nycomed GmbH | Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors |
| US7365215B2 (en) * | 2003-07-14 | 2008-04-29 | Ube Industries, Ltd. | Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same |
| AR045258A1 (es) * | 2003-08-21 | 2005-10-19 | Altana Pharma Ag | Un producto farmaceutico para inyeccion |
| US20060085924A1 (en) * | 2004-10-13 | 2006-04-27 | Gaelle Brun | Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer |
| AU2006205797A1 (en) * | 2005-01-12 | 2006-07-20 | 4Sc Ag | Pyrrolodihydroisoquinolines as antiproliferative agents |
| DE602006006544D1 (de) * | 2005-01-12 | 2009-06-10 | Nycomed Gmbh | Neue pyrrolodihydroisochinoline als pde10-inhibitoren |
| US8599822B2 (en) * | 2005-03-23 | 2013-12-03 | Cisco Technology, Inc. | Slot-based transmission synchronization mechanism in wireless mesh networks |
| FR2884251B1 (fr) * | 2005-04-08 | 2007-07-13 | Servier Lab | Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
| US8604031B2 (en) | 2006-05-18 | 2013-12-10 | Mannkind Corporation | Intracellular kinase inhibitors |
| RU2460727C2 (ru) | 2007-03-22 | 2012-09-10 | Астразенека Аб | Хинолиновые производные для лечения воспалительных заболеваний |
| PE20091036A1 (es) | 2007-11-30 | 2009-08-15 | Astrazeneca Ab | Derivado de quinolina como antagonista del receptor p2x7 |
| TW200944523A (en) * | 2008-02-08 | 2009-11-01 | Organon Nv | (Dihydro)pyrrolo[2,1-a]isoquinolines |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2692264B1 (fr) * | 1992-06-12 | 1994-08-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant. |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
-
1997
- 1997-03-27 FR FR9703760A patent/FR2761358B1/fr not_active Expired - Fee Related
-
1998
- 1998-03-12 CA CA002232116A patent/CA2232116C/fr not_active Expired - Fee Related
- 1998-03-26 DE DE69824332T patent/DE69824332T2/de not_active Expired - Fee Related
- 1998-03-26 PL PL325575A patent/PL194118B1/pl not_active IP Right Cessation
- 1998-03-26 DK DK98400711T patent/DK0867436T3/da active
- 1998-03-26 PT PT98400711T patent/PT867436E/pt unknown
- 1998-03-26 NZ NZ330041A patent/NZ330041A/xx unknown
- 1998-03-26 EP EP98400711A patent/EP0867436B1/fr not_active Expired - Lifetime
- 1998-03-26 CN CN98109437A patent/CN1090628C/zh not_active Expired - Fee Related
- 1998-03-26 ES ES98400711T patent/ES2223110T3/es not_active Expired - Lifetime
- 1998-03-26 AT AT98400711T patent/ATE268767T1/de not_active IP Right Cessation
- 1998-03-27 BR BR9803295A patent/BR9803295A/pt not_active Application Discontinuation
- 1998-03-27 JP JP10081710A patent/JPH10279578A/ja active Pending
- 1998-03-27 NO NO19981415A patent/NO314628B1/no unknown
- 1998-03-27 ZA ZA982607A patent/ZA982607B/xx unknown
- 1998-03-27 AU AU59677/98A patent/AU731018B2/en not_active Ceased
- 1998-03-27 US US09/049,233 patent/US5965575A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2232116C (fr) | 2003-09-16 |
| DK0867436T3 (da) | 2004-10-04 |
| AU5967798A (en) | 1998-10-01 |
| FR2761358B1 (fr) | 1999-05-07 |
| BR9803295A (pt) | 2000-03-21 |
| HK1014954A1 (en) | 1999-10-08 |
| NO981415D0 (no) | 1998-03-27 |
| JPH10279578A (ja) | 1998-10-20 |
| DE69824332D1 (de) | 2004-07-15 |
| NO314628B1 (no) | 2003-04-22 |
| PL194118B1 (pl) | 2007-04-30 |
| ATE268767T1 (de) | 2004-06-15 |
| CA2232116A1 (fr) | 1998-09-27 |
| DE69824332T2 (de) | 2005-06-16 |
| CN1090628C (zh) | 2002-09-11 |
| US5965575A (en) | 1999-10-12 |
| NO981415L (no) | 1998-09-28 |
| EP0867436A1 (fr) | 1998-09-30 |
| EP0867436B1 (fr) | 2004-06-09 |
| PL325575A1 (en) | 1998-09-28 |
| PT867436E (pt) | 2004-09-30 |
| AU731018B2 (en) | 2001-03-22 |
| FR2761358A1 (fr) | 1998-10-02 |
| CN1197072A (zh) | 1998-10-28 |
| ZA982607B (en) | 1998-09-30 |
| ES2223110T3 (es) | 2005-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL325575A1 (en) | Novel n-aryl piperidine compounds, method of obtaining them and pharmaceutic composition containing such compounds | |
| FI933357A0 (fi) | Foerfarande foer framstaellning av benzamider | |
| DE69325944D1 (de) | s-Triazinderivate als Lichtschutzmittel | |
| EE200900004A (et) | Dopamiini neurotransmissiooni modulaatorid, nende kasutamine ja neid hendeid sisaldavad farmatseutilised kompositsioonid | |
| NO932607L (no) | Piperidinderivater og anvendelse av disse | |
| IL124944A (en) | Quinolonecarboxylic acid derivatives or their salts and pharmaceutical compositions containing them | |
| ATE204574T1 (de) | Piperazin-, piperidin- und 1,2,5,6- tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
| ATE184610T1 (de) | Thiazolo(5,4-b>azepinverbindungen | |
| NO881525D0 (no) | Fremgangsmaate for fremstilling av antimikrobielle aromatiske derivater. | |
| HUT75647A (en) | Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia | |
| DK0585116T3 (da) | 1-alkoxy-naphthalen-2-carboxamidderivater med høj affinitet for serotonin 5HT1A receptoren | |
| AU646611B2 (en) | 4-{4- or 6-(trifluoromethyl-2-pyridinyl)}-1-piperazinyl- alkyl substituted lactams | |
| FI912499A0 (fi) | Pyrido/3,4-b/pyrrolo/1,2-e//1,4,5/ oxadiazepiner och daermed naerbeslaektade analoger, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| HU9600597D0 (en) | 4-alkylthio-pyrimidin-5-yl acetic acid derivates and fungicidal compositions containing them as an active ingredient | |
| ATE148116T1 (de) | Piperidin-derivate mit antihistaminischer und antileukomenischer wirkung | |
| AU2002214266A1 (en) | Carbamate derivatives, process for producing the same and use thereof | |
| HUP9800687A1 (hu) | N-aril-piperidin-származékok, eljárás előállításukra, és e vegyületeket tartalmazó gyógyszerkészítmények | |
| NO983602D0 (no) | Nye bis-pyrido£4,3-b|karbazolforbindelser, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger som inneholder disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: LES LABORATOIRES SERVIER, FR Free format text: OLD OWNER(S): ADIR ET COMPAGNIE |
|
| RENW | Renewal (renewal fees accepted) |